These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32664155)

  • 1. Reliability of digital PCR in detecting KRAS mutation in colorectal cancer using plasma sample: A systematic review and meta-analysis.
    Ye P; Cai P; Xie J; Zhang J
    Medicine (Baltimore); 2020 Jul; 99(28):e21171. PubMed ID: 32664155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A systematic review and meta-analysis.
    Ye P; Cai P; Xie J; Wei Y
    PLoS One; 2021; 16(3):e0248775. PubMed ID: 33770081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta-analysis.
    Xie W; Xie L; Song X
    Cancer Med; 2019 Mar; 8(3):1218-1231. PubMed ID: 30791218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A protocol for systematic review and meta-analysis.
    Ye P; Cai P; Xie J; Wei Y
    Medicine (Baltimore); 2020 Jun; 99(26):e20708. PubMed ID: 32590745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of BRAF mutation detection using plasma sample: A systematic review and meta-analysis.
    Ye P; Cai P; Xie J; Zhang J
    Medicine (Baltimore); 2021 Dec; 100(51):e28382. PubMed ID: 34941166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis.
    Westwood M; van Asselt T; Ramaekers B; Whiting P; Joore M; Armstrong N; Noake C; Ross J; Severens J; Kleijnen J
    Health Technol Assess; 2014 Oct; 18(62):1-132. PubMed ID: 25314637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of F-18 FDG PET/CT for prediction of KRAS mutation in colorectal cancer patients: a systematic review and meta-analysis.
    Kim SJ; Pak K; Kim K
    Abdom Radiol (NY); 2019 May; 44(5):1703-1711. PubMed ID: 30603881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor DNA is effective for detection of KRAS mutation in colorectal cancer: a meta-analysis.
    Tang M; Deng Z; Li B; Peng Y; Song M; Liu J
    Int J Biol Markers; 2017 Oct; 32(4):e421-e427. PubMed ID: 28885658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS p.G13D mutation and codon 12 mutations are not created equal in predicting clinical outcomes of cetuximab in metastatic colorectal cancer: a systematic review and meta-analysis.
    Mao C; Huang YF; Yang ZY; Zheng DY; Chen JZ; Tang JL
    Cancer; 2013 Feb; 119(4):714-21. PubMed ID: 22972628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of KRAS Mutations in Plasma DNA Using a fully Automated Rapid Detection System in Colorectal Cancer Patients.
    Hosoya K; Matsusaka S; Kashiwada T; Suzuki K; Ureshino N; Sato A; Miki Y; Kitera K; Hirai M; Hatake K; Kimura S; Sueoka-Aragane N
    Pathol Oncol Res; 2017 Oct; 23(4):737-744. PubMed ID: 28058585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery.
    Denis JA; Patroni A; Guillerm E; Pépin D; Benali-Furet N; Wechsler J; Manceau G; Bernard M; Coulet F; Larsen AK; Karoui M; Lacorte JM
    Mol Oncol; 2016 Oct; 10(8):1221-31. PubMed ID: 27311775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of
    Cai P; Yang B; Zhao J; Ye P; Yang D
    Front Oncol; 2023; 13():1207892. PubMed ID: 37483491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: Anti-epidermal growth factor receptor treatment effect modification by KRAS mutations in advanced colorectal cancer.
    Dahabreh IJ; Terasawa T; Castaldi PJ; Trikalinos TA
    Ann Intern Med; 2011 Jan; 154(1):37-49. PubMed ID: 21200037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAS status and resistance to epidermal growth factor receptor tyrosine-kinase inhibitor treatment in patients with metastatic colorectal cancer: a meta-analysis.
    Li W; Shi Q; Wang W; Liu J; Ren J; Li Q; Hou F
    Colorectal Dis; 2014 Nov; 16(11):O370-8. PubMed ID: 25155261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis.
    Shen H; Che K; Cong L; Dong W; Zhang T; Liu Q; Du J
    Oncotarget; 2017 May; 8(22):36812-36823. PubMed ID: 28415658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Droplet digital PCR revealed high concordance between primary tumors and lymph node metastases in multiplex screening of KRAS mutations in colorectal cancer.
    Vanova B; Kalman M; Jasek K; Kasubova I; Burjanivova T; Farkasova A; Kruzliak P; Busselberg D; Plank L; Lasabova Z
    Clin Exp Med; 2019 May; 19(2):219-224. PubMed ID: 30661213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of
    Olmedillas-López S; Lévano-Linares DC; Alexandre CLA; Vega-Clemente L; Sánchez EL; Villagrasa A; Ruíz-Tovar J; García-Arranz M; García-Olmo D
    World J Gastroenterol; 2017 Oct; 23(39):7087-7097. PubMed ID: 29093617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.
    Xu JM; Liu XJ; Ge FJ; Lin L; Wang Y; Sharma MR; Liu ZY; Tommasi S; Paradiso A
    J Exp Clin Cancer Res; 2014 Dec; 33(1):104. PubMed ID: 25491325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status and quality of radiomic studies for predicting KRAS mutations in colorectal cancer patients: A systematic review and meta‑analysis.
    Jia LL; Zhao JX; Zhao LP; Tian JH; Huang G
    Eur J Radiol; 2023 Jan; 158():110640. PubMed ID: 36525703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediagnosis Plasma Adiponectin in Relation to Colorectal Cancer Risk According to KRAS Mutation Status.
    Inamura K; Song M; Jung S; Nishihara R; Yamauchi M; Lochhead P; Qian ZR; Kim SA; Mima K; Sukawa Y; Masuda A; Imamura Y; Zhang X; Pollak MN; Mantzoros CS; Harris CC; Giovannucci E; Fuchs CS; Cho E; Chan AT; Wu K; Ogino S
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26598515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.